Sequana Medical NV (SEQUA) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.254x

Based on the latest financial reports, Sequana Medical NV (SEQUA) has a cash flow conversion efficiency ratio of 0.254x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-9.93 Million ≈ $-11.61 Million USD) by net assets (€-39.17 Million ≈ $-45.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sequana Medical NV (SEQUA) net asset quality to measure how much of total assets are equity-financed.

Sequana Medical NV - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Sequana Medical NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Sequana Medical NV debt service capacity to assess how comfortably operating cash covers total debt obligations.

Sequana Medical NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sequana Medical NV ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mildex Optical TWO:4729	0.002x
Francotyp-Postalia Holding AG F:FPH	0.005x
Changhae Ethanol Co. Ltd KQ:004650	0.102x
Kinetiko Energy Ltd AU:KKO	-0.033x
Finger Inc. KQ:163730	0.073x
Hoang Quan Consulting Trading Service Real Estate Corp VN:HQC	0.115x
Victory Square Technologies Inc F:6F6	0.006x
Daelim B&Co KO:005750	-0.002x

Annual Cash Flow Conversion Efficiency for Sequana Medical NV (2015–2024)

The table below shows the annual cash flow conversion efficiency of Sequana Medical NV from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see SEQUA market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-44.38 Million ≈ $-51.88 Million	€-20.26 Million ≈ $-23.68 Million	0.456x	-69.43%
2023-12-31	€-19.47 Million ≈ $-22.76 Million	€-29.06 Million ≈ $-33.98 Million	1.493x	-88.30%
2022-12-31	€-2.15 Million ≈ $-2.52 Million	€-27.48 Million ≈ $-32.13 Million	12.763x	-57.47%
2021-12-31	€-786.92K ≈ $-919.99K	€-23.62 Million ≈ $-27.61 Million	30.012x	+119.90%
2020-12-31	€112.76K ≈ $131.83K	€-17.01 Million ≈ $-19.88 Million	-150.806x	-655.51%
2019-12-31	€925.93K ≈ $1.08 Million	€-18.48 Million ≈ $-21.61 Million	-19.961x	-3891.86%
2018-12-31	€-18.76 Million ≈ $-21.93 Million	€-9.88 Million ≈ $-11.55 Million	0.526x	-72.08%
2017-12-31	€-4.61 Million ≈ $-5.39 Million	€-8.69 Million ≈ $-10.16 Million	1.885x	-1.40%
2016-12-31	€-6.67 Million ≈ $-7.80 Million	€-12.75 Million ≈ $-14.90 Million	1.912x	-95.17%
2015-12-31	€-284.66K ≈ $-332.79K	€-11.26 Million ≈ $-13.16 Million	39.554x	--

About Sequana Medical NV

BR:SEQUA Belgium Medical Devices

Market Cap

$55.84 Million

€47.76 Million EUR

Market Cap Rank

#22022 Global

#92 in Belgium

Share Price

€0.61

Change (1 day)

+0.00%

52-Week Range

€0.47 - €1.49

All Time High

€11.80